Clinical trial
Cholinergic Modulation of Condition and Emotion in Mood Disorders: Functional…
NCT00055575 · National Institute of Mental Health (NIMH), NIH · Terminated
Key facts
| NCT number | NCT00055575 |
|---|---|
| Title | Cholinergic Modulation of Condition and Emotion in Mood Disorders: Functional Neuroimaging Studies |
| Official title | Cholinergic Modulation of Cognition and Emotion in Mood Disorders: Functional Neuroimaging Studies |
| Lead sponsor | National Institute of Mental Health (NIMH), NIH |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Mood Disorders, Healthy, Unipolar Depression, Bipolar Depression |
| Intervention type | Drug |
| Interventions | Scopolamine Nasal Spray |
| Enrollment | 197 |
| Start date | Feb 27, 2003 |
| Primary completion | Feb 2, 2015 |
| Completion | Feb 2, 2015 |
| First posted | Mar 6, 2003 |
| Last update posted | Mar 22, 2021 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: